CEFIP deficiency in mice enhances glucose tolerance despite compromised muscle function

Area of Science:

• Skeletal muscle physiology
• Molecular biology
• Metabolic regulation

Background:

• Mechanotransduction in skeletal muscles is vital for physical performance but poorly understood.
• Key regulatory molecules balancing muscle strength and metabolism are yet to be identified.
• Cardiac-enriched FHL2-interacting protein (CEFIP) is a Z-disc protein upregulated with contractility.

Purpose of the Study:

• To investigate the role of CEFIP in skeletal muscle mechanotransduction.
• To determine CEFIP's influence on physical performance and glucose metabolism.
• To elucidate the molecular mechanisms underlying CEFIP's function.

Main Methods:

• Analysis of CEFIP-deficient mouse models.
• Assessment of physical fitness parameters (running, grip strength).
• Molecular analysis of gene expression (STARS, FHL1, FHL3, PGC-1α) and protein phosphorylation (AMPK, GLUT4 translocation).

Main Results:

• CEFIP deficiency decreased physical fitness and running capacity.
• CEFIP deficiency led to altered expression of mechanosensitive factors (STARS, FHL1, FHL3).
• CEFIP-deficient mice showed enhanced insulin sensitivity, increased AMPK phosphorylation, and greater GLUT4 translocation.

Conclusions:

• CEFIP acts as a critical regulator linking exercise performance and metabolic properties in skeletal muscle.
• CEFIP may mediate these effects through Z-disc-based mechanosensitive pathways.
• Proper CEFIP regulation is essential for physiological homeostasis, though its precise role in wild-type muscle requires further study.